39.66
price down icon2.84%   -1.16
after-market Handel nachbörslich: 39.66
loading

Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-09-30
Periodenlänge 3 Monate 3 Monate
Revenues
-
-
Operating Expenses
57.09%
38.18
24.30
Operating Income/Loss
57.09%
-38.18
-24.30
Income/Loss From Continuing Operations Before Tax
54.00%
-32.09
-20.84
Income/Loss From Continuing Operations After Tax
54.00%
-32.09
-20.84
Net Income/Loss
54.00%
-32.09
-20.84
Preferred Stock Dividends And Other Adjustments
-
-
Attributable To Noncontrolling Interest
-
-
Basic Average Shares
21.73%
50.19
41.23
Diluted Average Shares
21.73%
50.19
41.23
Basic Earnings Per Share
25.49%
-0.64
-0.51
Diluted Earnings Per Share
25.49%
-0.64
-0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
-
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):